A recently approved drug for treatment-resistant depression was branded as a wonder drug, but serious questions have been raised about its approval process, effectiveness and safety, the Center for Public Integrity reports.
Why it matters: "For veterans whose ranks are plagued by depression and suicides, much is at stake," CPI writes. "A drug that offers [a] fast and lasting answer for treatment-resistant depression would be a godsend. But is this drug the answer?"